A 2011 study of elite athletes losing weight at different rates found that those losing weight slowly (around 0.7% of body weight a week) gained 2.1% lean mass over the study
In these studies, pregnant or neonate mice are given doses equivalent to or in excess of recommended dosage for pregnant women
(2020)) and unpublished data generated after that experimental study, but before the conception of this computational study
These findings are derived from a small number of trials, and the overall ASD sample size remains limited, which restricts the generalizability of the results
The medications have proven especially lucrative for Lilly and Novo
The search period was restricted to January 1, 2000, through May 6, 2025, as GLP-1 receptor agonists began entering clinical research in the early 2000s